CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.800
+0.120 (4.48%)
Feb 21, 2025, 4:00 PM EST - Market closed
CytoMed Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 32 | 56 | - | - | - | - |
| Enterprise Value | 28 | 49 | - | - | - | - |
| Last Close Price | 2.80 | 4.90 | - | - | - | - |
| PS Ratio | 97.84 | 146.86 | - | - | - | - |
| PB Ratio | 4.31 | 6.63 | - | - | - | - |
| P/TBV Ratio | 3.21 | 6.64 | - | - | - | - |
| EV/Sales Ratio | 83.56 | 127.72 | - | - | - | - |
| Debt / Equity Ratio | 0.04 | 0.04 | 7.20 | 1.26 | 6.27 | 0.35 |
| Asset Turnover | 0.04 | 0.06 | 0.06 | 0.02 | 0.02 | - |
| Inventory Turnover | - | 0.01 | 0.02 | 0.01 | 0.03 | - |
| Quick Ratio | 19.20 | 12.83 | 0.39 | 0.86 | 0.35 | 1.22 |
| Current Ratio | 21.53 | 14.08 | 0.60 | 1.12 | 0.54 | 1.46 |
| Return on Equity (ROE) | -26.26% | -69.87% | -197.08% | -133.79% | -161.72% | - |
| Return on Assets (ROA) | -17.44% | -27.30% | -20.55% | -21.98% | -24.47% | - |
| Return on Capital (ROIC) | -17.87% | -29.12% | -21.82% | -23.38% | -27.26% | - |
| Earnings Yield | -6.99% | -5.54% | - | - | - | - |
| FCF Yield | -8.13% | -4.68% | - | - | - | - |
| Buyback Yield / Dilution | -29.10% | -34.30% | -14.14% | -17.59% | -6.22% | - |
| Total Shareholder Return | -29.10% | -34.30% | -14.14% | -17.59% | -6.22% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.